Urinalysis Market Size, Share, Growth Analysis, By Product(Consumables [Pregnancy & Fertility Kits, Dipsticks, Reagents, Disposables]), By Test Type(Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, POC Tests], Sediment Urinalysis), By Application(Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases), By End User(Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, Research Laboratories & Institutes), By Region - Industry Forecast 2024-2031

Urinalysis Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031)

The global urinalysis market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Siemens Healthineers AG  (Germany) ', 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Cardinal Health (US) ', 'Danaher (US) ', 'Abbott (US) ', 'Sysmex Corporation (Japan) ', 'Thermo Fisher Scientific (US) ', 'QuidelOrtho Corporation (US) ', 'Becton, Dickinson and Company (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'EKF Diagnostics Holdings PLC (UK) ', 'Arkray, Inc. (Japan) ', 'ACON Laboratories, Inc. (US) ', '77 Elektronika Kft. (Hungary) ', 'URIT Medical Electronic Co., Ltd. (China) ', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) ', 'Dirui Industrial Co., Ltd. (China) ', 'BIOBASE Group (China) ', 'Erba Mannheim (Germany) ', 'Alphatec Scientific E.I.R.L. (Peru) ', 'Teco Diagnostics (US) ', 'Analyticon Biotechnologies GmbH (Germany) ', 'Bioway Biological Technology Co., Ltd. (China) ', 'High Technology, Inc. (US) ', 'Agappe Diagnostics Ltd (India) ', 'Toyobo Co., Ltd. (Japan) ', 'DIALAB GmbH (Austria) ', 'Quantimetrix (US) ', 'Biocare Corporation (Taiwan) ', 'Randox Laboratories Ltd. (UK) ', 'PZ Cormay S.A. (Poland) ', 'YD Diagnostics (South Korea) ', 'Contec Medical Systems Co., Ltd. (China) ', 'Biopanda Reagents Ltd. (UK)'

The growing cases of chronic diseases like kidney diseases and diabetes is increasing the use and demand for urinalysis on a large scale. These health conditions, if not regularly tested and monitored, may result in more complications. This increases the need for routine monitoring and encourages better patient outcomes. Also, the growing number of UTIs demand better diagnosis via urinalysis, impacting reliable testing services. 

Growth of Product Offerings: The development of improved test strips that can capably notice a broader range of biomarkers and offer more exhaustive outcomes is currently trending in the market. The integration of digital tolls and technologies for data management and analysis considerably improves record-keeping and interpretation. These trends are projected to fuel the urinalysis market 

Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the presence of advanced healthcare infrastructure and growing cases of chronic illnesses. North America holds well-developed healthcare systems with quality laboratory services and improved diagnostic tools and technologies. Regional growth is also impacted by the growing prevalence of chronic ailments like kidney disorders, diabetes, and urinary infections that demand urinalysis on a large scale. Moreover, a notable emphasis on preventive health measures and routine screenings fuels the need for urinalysis. The key players profiled in the region include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton, Dickinson and Company, Sysmex Corporation, and more.